Search results for "Treatment monitoring"

showing 3 items of 3 documents

Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell L…

2022

Background: Despite the increasing implementation of targeted and immunotherapy-based treatments, the prognosis of patients with advanced NSCLC remains dismal. We prospectively evaluated longitudinal plasma cfDNA kinetics as an early marker of therapeutic efficacy in patients with advanced NSCLC undergoing standard first-line treatments. Methods: From February 2020 to May 2022, treatment-naïve patients with advanced NSCLC were consecutively enrolled at the Medical Oncology Unit of the Paolo Giaccone University Hospital, Palermo (Italy). We quantified cfDNA in terms of ng/μL using a QubitTM dsDNA HS Assay Kit. The agreement between the cfDNA and radiologic response was evaluated from…

treatment monitoringCancer Researchliquid biopsyOncologyECOG-PS 2cfDNANSCLCNSCLC; liquid biopsy; cfDNA; treatment monitoring; ECOG-PS 2Cancers
researchProduct

Mosaic floors of roman Villa del Casale: Principal component analysis on spectrophotometric and colorimetric data

2013

Abstract Spectrophotometric and colorimetric data obtained during a measurement campaign aimed at supporting the Roman "Villa del Casale" (Piazza Armerina, Sicily, Italy) conservation activities, are presented. Special attention was paid to the possible variation of the chromatic coordinates, possibly due to the interventions of cleaning, consolidation, and protection. Data have been analyzed by the Principal Component Analysis (PCA) statistical technique, with the attempt to investigate its role in data variability reduction and verify its effectiveness in interpreting the phenomena occurring on the mosaic surface of the Villa, through grouping the observations into homogenous clusters. Ef…

ArcheologyData variabilityComputer scienceMaterials Science (miscellaneous)Spectrophotometric dataConservationAuthor keywords Colorimetric dataPrincipal Component AnalysiTreatment monitoringColor measurementChromatic scaleCluster analysisSpectroscopyVilla del Casalebusiness.industryData interpretationPattern recognitionArchaeologySettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Chemistry (miscellaneous)Principal component analysisMosaic floorArtificial intelligencebusinessGeneral Economics Econometrics and FinanceTreatment monitoring
researchProduct

Technical Aspects for the Evaluation of Circulating Tumor Cells (CTCs)

2017

Liquid biopsy is considered a valid strategy to improve patients’ selection and treatment monitoring in clinical practice. Indeed Circulating Tumor Cells (CTCs) represent an important component of liquid biopsy and their clinical evaluation is becoming fundamental for a better patients’ stratification. Several techniques have been developed for CTCs isolation and enrichment and in this chapter we provide an updated overview of the main strategies that can be used.

OncologyClinical Practicemedicine.medical_specialtyCirculating tumor cellbusiness.industryInternal medicineMedicineLiquid biopsybusinessClinical evaluationCirculating Tumor CellsTreatment monitoring
researchProduct